Daniel Peck joined Vestaron Corp. a year ago in what became a timely indoctrination into the fledgling company’s mission to improve the safety, efficacy and sustainability of crop protection through displacement of chemical pesticides with biological peptides.
Peck, a Ph.D. who earned his doctorate in entomology from Cornell University, is a field development biologist who brought to Vestaron 25 years of experience in insect pest management.
Vestaron, with headquarters in Durham, North Carolina, registered and released two formulations of its Spear bioinsecticide in the U.S. The first, Spear-T, was approved by the U.S. EPA in 2018. It is a concentrated liquid formulation designed for contact activity against a broad range of insect and mite pests in the greenhouse.
The second, Spear-Lep, was approved in 2019. This product targets lepidopteran (caterpillar) pests in outdoor and indoor crops where a reduced rate of Spear is applied with a synergist (Bt) to achieve efficacy through ingestion.
With the recent Insecticide Resistance Action Committee (IRAC) approval of a novel mode of action for the Spear brand family of products, Vestaron believes it is building a commercial phase onto its research and development foundation.
Vestaron